Quality Assurance

Data quality assurance is our core service

Data quality is at the heart of everything at Avance Clinical. Delivered by our highly experienced staff we support our clients with their clinical trial audit to achieve their quality objectives for their clinical research trials.

Our independent Quality Assurance team provides a full range of independent Quality Assurance services. Our auditors have vast experience in conducting clinical trial audits in various phases and therapeutic indications, across several countries including APAC, EU, and USA.

Technology

The company has focussed on state-of-the-art technology and systems across all functional areas to provide clients with the most effective processes. Medidata, Oracle, and Medrio are just some of the technology partners.

Avance Clinical offers globally accepted data from an established clinical trial ecosystem, that includes world-class PIs and Sites that are able to rapidly access specialized patient groups.

Quality Assurance Services

Avance Clinical offers the region’s most sophisticated quality assurance services because this is at the heart of everything we do.

The Australian Government R&D grant means up to 43.5% rebate on clinical trial spend
No IND required for clinical trials
Site Initiation Visit (SIV) and Study Start can be achieved in 5 – 6 weeks
Globally accepted data

Services Overview

Investigator Site Audits

Vendor Audits

Audit of Phase 1 units

Database/Data Management Audits

Trial Master File Audits

Clinical Study Report Audits

Quality System Audits

Quality Assurance

Learn more about how we work

Request a Proposal or Talk to our Team  CONTACT US

More benefits

Avance Clinical can leverage all the benefits of Australia and New Zealand’s clinical ecosystem to deliver your study

Almost half clinical costs

The Government R&D grant means up to 43.5% rebate on clinical trial spend

Rapid Start-up

Site Initiation Visit (SIV) and Study Start can be achieved in 5 – 6 weeks

Start-up time

Site Initiation Visit (SIV) and Study Start can be achieved in 5 – 6 weeks

No IND

No IND required for clinical trials

GMP material

Full GMP material is not mandated for Phase I clinical trials

Gene-therapy accreditation

Avance Clinical is an accredited gene-therapy CRO

Seasonal studies

Northern hemisphere Sponsors can conduct their studies year-round by taking advantage of Australia and New Zealand's counter-flu and allergy seasons

FDA and global regulatory data compliance

Major hospitals with world-class infrastructures and dedicated Clinical Trial Units with a long track record in FDA compliant research

Rebate

The Government R&D grant means up to 43.5% rebate on clinical trial spend

Start-up time

Site Initiation Visit (SIV) and Study Start achieved in 5 – 6 weeks

Capabilities

Full service CRO in Australia and New Zealand

195
Studies in the past 5 years
150
Experienced Team Members
10,000
Study Participants (5 years)
24
Years of of CRO experience

“Within Asia-Pacific’s highly competitive CRO market, Avance Clinical stands out as a leader in early phase biotech clinical trials.

The company offers a highly responsive and proactive service for biotechs wanting rapid and innovative clinical trial solutions, with the highest level of data compliance. Avance Clinical offers a real size match for biotechs that means better mission understandings and stronger customer service compared to some of the larger CROs.”

Nidhi JalaliAnalyst Best Practices, Frost & Sullivan

Ready To Partner with Us?

Contact Us